W. Principaux-repères-sur-l'obésité and . Le-surpoids, , 2017.

, Collège National des Gynécologues et Obstétriciens Français. Conséquences obstétricales de l'obésité maternelle, 2007.

H. Haute, Autorité de Santé-Surpoids et obésité de l'adulte : prise en charge médicale de premier recours, recommandations pour la pratique clinique, 2011.

S. Geneva and W. H. Organization, Obésité : prévention et prise en charge de l' épidémie mondiale : rapport d' une consultation de l' OMS. Obesity : preventing and managing the global epidemic : report of a WHO consultation, WHO Consultation on Obesity, 1997.

. Disponible,

K. Inserm and R. Health, ObEpi-Roche, enquête épidémiologique de référence sur l'évolution de l'obésité et du surpoids en France, 2012.

. Disponible,

, /index.html?module1&module2&module3&module4&module5&module6

. Inserm-epopé, Enquête nationale périnatale 2016-Les naissances et les établissements, situation et évolution depuis, 2010.

. Disponible,

J. L. Weiss, F. D. Malone, D. Emig, R. H. Ball, D. A. Nyberg et al., Obesity, obstetric complications and cesarean delivery rate-a population-based screening study, Am J Obstet Gynecol. avr, vol.190, issue.4, pp.1091-1098, 2004.

M. I. Cedergren, Maternal morbid obesity and the risk of adverse pregnancy outcome, Obstet Gynecol. févr, vol.103, issue.2, pp.219-243, 2004.

N. J. Sebire, M. Jolly, J. P. Harris, J. Wadsworth, M. Joffe et al., Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London, Int J Obes Relat Metab Disord J Int Assoc Study Obes. août, vol.25, issue.8, pp.1175-82, 2001.

, Rapport de synthèse sur le dépistage et le diagnostic du diabète gestationnel, HAS, 2005.

B. Hoegsberg, P. A. Gruppuso, and D. R. Coustan, Hyperinsulinemia in macrosomic infants of nondiabetic mothers, Diabetes Care. janv, vol.16, issue.1, pp.32-38, 1993.

A. Guedj, Quand dépister le diabète gestationnel ?, J Gynécologie Obstétrique Biol Reprod. 1 déc, vol.39, issue.8, pp.214-223, 2010.

, Collège National des Gynécologues et Obstétriciens Français. Recommandations pour la pratique clinique-Le diabète gestationnel

C. Hamon, S. Fanello, L. Catala, and E. Parot, Maternal obesity: effects on labor and delivery: Excluding other diseases that might modify obstetrical management, J Gynecol Obstet Biol Reprod (Paris). avr, vol.34, issue.2, pp.109-123, 2005.

R. Gilead, Y. Salem, S. Sergienko, R. Sheiner, and E. , Maternal « isolated » obesity and obstetric complications, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. déc, vol.25, issue.12, pp.2579-82, 2012.

P. M. Catalano, Management of obesity in pregnancy, Obstet Gynecol. févr, vol.109, issue.2, pp.419-452, 2007.

C. Yu, T. G. Teoh, and S. Robinson, Obesity in pregnancy, BJOG Int J Obstet Gynaecol, vol.113, issue.10, pp.1117-1142, 2006.

F. Vally, J. Presneill, and T. Cade, Macrosomia Rates in Women with Diet-Controlled Gestational Diabetes: A Retrospective Study, J Pregnancy, p.4935397, 2017.

H. Robinson, S. Tkatch, D. C. Mayes, N. Bott, and N. Okun, Is maternal obesity a predictor of shoulder dystocia?, Obstet Gynecol. janv, vol.101, issue.1, pp.24-31, 2003.

S. H. Mehta and R. J. Sokol, Shoulder dystocia: risk factors, predictability, and preventability, Semin Perinatol. juin, vol.38, issue.4, pp.189-93, 2014.

R. Scott-pillai, D. Spence, C. R. Cardwell, A. Hunter, and V. A. Holmes, The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, BJOG Int J Obstet Gynaecol. juill, vol.120, issue.8, pp.932-941, 2004.

V. Flenady, P. Middleton, G. C. Smith, W. Duke, J. J. Erwich et al., Stillbirths: the way forward in high-income countries, Lancet Lond Engl. 14 mai, vol.377, issue.9778, pp.1703-1720, 2011.

, Collège National des Gynécologues et Obstétriciens Français, 2012.

D. Subtil, P. Vaast, P. Dufour, S. Depret-mosser, X. Codaccioni et al., Maternal consequences of cesarean as related to vaginal delivery, J Gynecol Obstet Biol Reprod, vol.29, issue.2, pp.10-16, 2000.

E. Burstein, A. Levy, M. Mazor, A. Wiznitzer, and E. Sheiner, Pregnancy outcome among obese women: a prospective study, Am J Perinatol. oct, vol.25, issue.9, pp.561-567, 2008.

A. S. Poobalan, L. S. Aucott, T. Gurung, W. Smith, and S. Bhattacharya, Obesity as an independent risk factor for elective and emergency caesarean delivery in nulliparous women-systematic review and meta-analysis of cohort studies, Obes Rev. janv, vol.10, issue.1, pp.28-35, 2009.

T. Kawakita, U. M. Reddy, H. J. Landy, S. N. Iqbal, C. Huang et al., Indications for primary cesarean delivery relative to body mass index, Am J Obstet Gynecol, vol.215, issue.4, pp.515-516, 2016.

B. Fève, J. Bastard, and H. Vidal, Les relations entre obésité, inflammation et insulinorésistance : acquisitions récentes. /data/revues, 2008.

. Disponible,

D. Santos, E. Duval, F. Vialard, F. Dieudonné, and M. , The roles of leptin and adiponectin at the fetal-maternal interface in humans, Horm Mol Biol Clin Investig. oct, vol.24, issue.1, pp.47-63, 2015.

C. Hug, H. F. Lodish, and . Medicine, Visfatin: a new adipokine, Science. 21 janv, vol.307, issue.5708, pp.366-373, 2005.

I. Castan-laurell, J. Boucher, C. Dray, D. Daviaud, C. Guigné et al., Apelin, a novel adipokine over-produced in obesity: friend or foe?, Mol Cell Endocrinol. 21 déc, vol.245, issue.1-2, pp.7-9, 2005.

R. Jockers, Institut Cochin-Le récepteur de la leptine et rôle dans le développement de l'obésité et du diabète de type 2

J. Be?towski, Apelin and visfatin: unique « beneficial » adipokines upregulated in obesity?, Med Sci Monit Int Med J Exp Clin Res. juin, vol.12, issue.6, pp.112-119, 2006.

J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigné et al., Apelin, a newly identified adipokine up-regulated by insulin and obesity, Endocrinology. avr, vol.146, issue.4, pp.1764-71, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00480981

S. Han, E. W. Englander, G. A. Gomez, C. Rastellini, T. Quertermous et al., Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice, Endocrinology. juill, vol.156, issue.7, pp.2451-60, 2015.

M. Lafontan and N. Viguerie, Role of adipokines in the control of energy metabolism: focus on adiponectin, Curr Opin Pharmacol. déc, vol.6, issue.6, pp.580-585, 2006.

R. Señarís, T. Garcia-caballero, X. Casabiell, R. Gallego, R. Castro et al., Synthesis of leptin in human placenta, Endocrinology. oct, vol.138, issue.10, pp.4501-4505, 1997.

H. Masuzaki, Y. Ogawa, N. Sagawa, K. Hosoda, T. Matsumoto et al., Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans, Nat Med. sept, vol.3, issue.9, pp.1029-1062, 1997.

D. M. Farley, J. Choi, D. J. Dudley, C. Li, S. L. Jenkins et al., Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity, Placenta. août, vol.31, issue.8, pp.718-742, 2010.

P. Tsai, J. Davis, and G. Bryant-greenwood, Systemic and placental leptin and its receptors in pregnancies associated with obesity, Reprod Sci Thousand Oaks Calif. févr, vol.22, issue.2, pp.189-97, 2015.

S. Hauguel-de-mouzon, J. Lepercq, and P. Catalano, The known and unknown of leptin in pregnancy, Am J Obstet Gynecol. juin, vol.194, issue.6, pp.1537-1582, 2006.

M. S. Esplin, M. B. Fausett, M. R. Peltier, S. Hamblin, R. M. Silver et al., The use of cDNA microarray to identify differentially expressed labor-associated genes within the human myometrium during labor, Am J Obstet Gynecol. août, vol.193, issue.2, pp.404-417, 2005.

J. Be?towski, Apelin and visfatin: unique « beneficial » adipokines upregulated in obesity?, Med Sci Monit Int Med J Exp Clin Res. juin, vol.12, issue.6, pp.112-119, 2006.

H. Azaïs, A. Leroy, L. Ghesquiere, P. Deruelle, and S. Hanssens, Effects of adipokines and obesity on uterine contractility, Cytokine Growth Factor Rev. avr, vol.34, pp.59-66, 2017.

J. E. Caminos, R. Nogueiras, R. Gallego, S. Bravo, S. Tovar et al., Expression and regulation of adiponectin and receptor in human and rat placenta, J Clin Endocrinol Metab. juill, vol.90, issue.7, pp.4276-86, 2005.

D. Benaitreau, D. Santos, E. Leneveu, M. , D. Mazancourt et al., Adiponectin promotes syncytialisation of BeWo cell line and primary trophoblast cells, Reprod Biol Endocrinol RBE, vol.8, p.128, 2010.

N. S. Carlson, T. L. Hernandez, and K. J. Hurt, Parturition dysfunction in obesity: time to target the pathobiology, Reprod Biol Endocrinol. déc, vol.13, issue.1, 2015.

K. Subbaramaiah, P. G. Morris, X. K. Zhou, M. Morrow, B. Du et al., Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women, Cancer Discov. avr, vol.2, issue.4, pp.356-65, 2012.

R. S. Suidan, K. C. Rondon, J. J. Apuzzio, and S. F. Williams, Labor outcomes of obese patients undergoing induction of labor with misoprostol compared to dinoprostone, Am J Perinatol. févr, vol.30, issue.2, pp.187-92, 2015.

C. M. Zelig, S. F. Nichols, B. M. Dolinsky, M. W. Hecht, and P. G. Napolitano, Interaction between maternal obesity and Bishop score in predicting successful induction of labor in term, nulliparous patients, Am J Perinatol. janv, vol.30, issue.1, pp.75-80, 2013.

J. Zhang, L. Bricker, S. Wray, and S. Quenby, Poor uterine contractility in obese women, BJOG Int J Obstet Gynaecol. 25 janv, vol.114, issue.3, pp.343-351, 2007.

A. T. Moynihan, M. P. Hehir, S. V. Glavey, T. J. Smith, and J. J. Morrison, Inhibitory effect of leptin on human uterine contractility in vitro, Am J Obstet Gynecol. août, vol.195, issue.2, pp.504-513, 2006.

R. Wuntakal and T. Hollingworth, Leptin-a tocolytic agent for the future? Med Hypotheses, janv, vol.74, issue.1, pp.81-83, 2010.

R. Wuntakal, M. Kaler, and T. Hollingworth, Women with high BMI: should they be managed differently due to antagonising action of leptin in labour? Med Hypotheses, juin, vol.80, issue.6, pp.767-775, 2013.

M. Barrichon, T. Hadi, M. Wendremaire, C. Ptasinski, R. Seigneuric et al., Dosedependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-?B pathway activation in human myometrial cells, Br J Pharmacol. juin, vol.172, issue.12, pp.2974-90, 2015.

S. Mumtaz, S. Alsaif, S. Wray, and K. Noble, Inhibitory effect of visfatin and leptin on human and rat myometrial contractility, Life Sci. 15 mars, vol.125, pp.57-62, 2015.

M. P. Hehir and J. J. Morrison, The adipokine apelin and human uterine contractility, Am J Obstet Gynecol. avr, vol.206, issue.4, pp.359-360, 2012.

R. Lim, G. Barker, C. Riley, and M. Lappas, Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells, Reprod Sci Thousand Oaks Calif. août, vol.20, issue.8, pp.957-67, 2013.

M. Wendremaire, M. Bardou, C. Peyronel, T. Hadi, P. Sagot et al., Effects of leptin on lipopolysaccharide-induced myometrial apoptosis in an in vitro human model of chorioamnionitis, Am J Obstet Gynecol, vol.205, issue.4, pp.363-364, 2011.

N. G. Reti, M. Lappas, C. Riley, M. E. Wlodek, M. Permezel et al., Why do membranes rupture at term? Evidence of increased cellular apoptosis in the supracervical fetal membranes, Am J Obstet Gynecol. mai, vol.196, issue.5, pp.484-485, 2007.

N. S. Carlson and N. K. Lowe, Intrapartum management associated with obesity in nulliparous women, J Midwifery Womens Health. févr, vol.59, issue.1, pp.43-53, 2014.

E. A. Mcdonald and M. W. Wolfe, The pro-inflammatory role of adiponectin at the maternalfetal interface, Am J Reprod Immunol N Y N, vol.66, issue.2, pp.128-164, 1989.

S. Arrowsmith, S. Wray, and S. Quenby, Maternal obesity and labour complications following induction of labour in prolonged pregnancy, BJOG Int J Obstet Gynaecol. avr, vol.118, issue.5, pp.578-88, 2011.

K. B. Wolfe, R. A. Rossi, and C. R. Warshak, The effect of maternal obesity on the rate of failed induction of labor, Am J Obstet Gynecol. août, vol.205, issue.2, pp.128-129, 2011.

V. R. Lee, B. G. Darney, J. M. Snowden, E. K. Main, W. Gilbert et al., Term elective induction of labour and perinatal outcomes in obese women: retrospective cohort study, BJOG Int J Obstet Gynaecol. janv, vol.123, issue.2, pp.271-279, 2016.

S. M. Norman, M. G. Tuuli, A. O. Odibo, A. B. Caughey, K. A. Roehl et al., The effects of obesity on the first stage of labor, Obstet Gynecol. juill, vol.120, issue.1, pp.130-135, 2012.

N. Melamed, O. Yariv, L. Hiersch, A. Wiznitzer, I. Meizner et al., Labor induction with prostaglandin E2: characteristics of response and prediction of failure, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. janv, vol.26, issue.2, pp.132-138, 2013.

T. Gauthier, S. Mazeau, F. Dalmay, J. Eyraud, C. Catalan et al., Obesity and cervical ripening failure risk, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. mars, vol.25, issue.3, pp.304-311, 2012.
DOI : 10.3109/14767058.2011.575485

URL : https://hal.archives-ouvertes.fr/hal-00933809

A. M. Maged, A. M. El-semary, H. M. Marie, D. S. Belal, A. Hany et al., Effect of maternal obesity on labor induction in postdate pregnancy, Arch Gynecol Obstet. 2 avr, 2018.

, Argumentaire-Déclenchement artificiel du travail, 2008.

A. , , 2015.

. Disponible,

V. , , 2018.

, Commission de la transparence-Cytotec 200 microgrammes, HAS, 2016.

. Disponible,

, Etat des lieux et expertise de l'usage hors AMM du misoprostol en gynécologieobstétrique : travail du CNGOF, 2013.

, Induction of labor, ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin, vol.114, issue.107, pp.386-97, 2009.

, Inducing labour | Guidance and guidelines | NICE, 2008.

H. Autorité-de-santé, Accouchement normal-Argumentaire, 2017.

. Disponible,

C. Dupont, M. Carayol, L. Ray, C. Barasinski, C. Beranger et al., Recommandations pour l'administration d'oxytocine au cours du travail spontané. Texte court des recommandations, Rev Sage-Femme. 1 févr, vol.16, issue.1, pp.111-119, 2017.

C. Y. Spong, V. Berghella, K. D. Wenstrom, B. M. Mercer, and G. R. Saade, Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop, Obstet Gynecol, vol.120, issue.5, pp.1181-93, 2012.

L. Wang, J. Zheng, W. Wang, J. Fu, and L. Hou, Efficacy and safety of misoprostol compared with the dinoprostone for labor induction at term: a meta-analysis, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.29, issue.8, pp.1297-307, 2016.

S. C. Austin, L. Sanchez-ramos, and C. D. Adair, Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysis, Am J Obstet Gynecol. juin, vol.202, issue.6, pp.624-625, 2010.

P. Rozenberg, S. Chevret, M. Sénat, F. Bretelle, P. Bonnal et al., A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress, Am J Obstet Gynecol. juill, vol.191, issue.1, pp.247-53, 2004.

G. Chiossi, M. M. Costantine, E. Bytautiene, T. Kechichian, G. Hankins et al., The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure, Am J Perinatol. sept, vol.29, issue.8, pp.615-637, 2012.

C. Dupont, M. Carayol, L. Ray, C. Barasinski, C. Beranger et al., Oxytocin administration during spontaneous labour: Guidelines for clinical practice. Guidelines short text, Gynecol Obstet Fertil Senol. janv, vol.45, issue.1, pp.56-61, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01467543

H. Ganer-herman, L. Tamayev, R. Houli, H. Miremberg, J. Bar et al., Risk factors for nonreassuring fetal heart rate tracings after artificial rupture of membranes in spontaneous labor, Birth Berkeley Calif. 24 avr, 2018.